The ConcertAI Podcast (ConcertAI)
Explorez tous les épisodes de The ConcertAI Podcast
| Date | Titre | Durée | |
|---|---|---|---|
| 15 Dec 2022 | Introduction by Host Jeff Elton | 00:01:00 | |
The ConcertAI Podcast is a monthly podcast which brings together subject matter experts who take a deeper dive on topics of interest and relevance like real world data, real world evidence, clinical development technologies and patient facing solutions for clinical diagnosis.
| |||
| 13 Jan 2023 | Multi-modal Data feat. Claudio D'Ambrosio | 00:17:46 | |
On our first episode, special guest Claudio D'Ambrosio covers the topic of multi-modal data in biomedical research. Multi-modal data can allow some of the deepest most advanced research questions to be answered. We start with the questions and then we bring together layers of different data, of different origin, that surround the patient in service of that particular question. This will change and transform how we develop and test hypothesis and will accelerate early phase trial activities. D'Ambrosio also touches on ConcertAI's value of partnering. Biomedical innovations is a team sport. It requires the inputs of multiple types of expertise. It’s in the dynamics operating as a single company or single entity that we can really transform the performance of research activities.
| |||
| 15 Feb 2023 | Clinical Development Technologies feat. Luke Dunlap | 00:29:48 | |
On this episode of The ConcertAI Podcast, we're joined by SVP of Clinical Development Technologies, Luke Dunlap. Luke and Jeff discuss the experience and transformation about how clinical trials are being conducted with some of the newest technologies and the value that's being realized. Take a deeper dive into our end-to-end software platform, Digital Trial Solutions, is being used to conduct pharmaceutical studies at clinical research sites and how it is subsequently reducing patient burden. You'll also hear about ConcertAI's Clinical Trial Optimization software system and how it is improving the efficiency of clinical research protocols. Learn how we are transforming and accelerating biomedical innovations over the course of the next two to five years.
| |||
| 01 Mar 2023 | Real World Data: Unlocking the Power of Patient Insights feat. Catherine Richards | 00:33:18 | |
Don't miss out on the latest episode of The ConcertAI Podcast featuring Catherine Richards, ConcertAI's chief data officer! Join us as we dive into the state of the field of real world data, why it's transforming, and how research is now enabled because of it. Tune in to gain more understanding about data sets and analyses derived from real world data. Click the link to listen now!
| |||
| 15 Mar 2023 | Revolutionizing Medical Imaging Using AI feat. TeraRecon's Dan McSweeney | 00:21:57 | |
In this episode of the ConcertAI podcast, join our CEO Jeff Elton and Dan McSweeney, President of TeraRecon, ConcertAI's digital imaging solution, for an informative and engaging discussion. TeraRecon is a leading solution for three-dimensional radiological interpretation, but what makes them stand out is their novel approach of integrating AI directly into care delivery models. Jeff and Dan explore the unique position of TeraRecon in the healthcare workflow and how their neutrality sets them apart from other players in the space. They also discuss the potential of AI in radiology and how it can reduce variation in clinical outcomes while increasing productivity. Don't miss out on this exciting exchange about healthcare technology and innovation. Tune in now to join the conversation!
| |||
| 01 Feb 2023 | Trial Diversity feat. Warren Whyte | 00:29:53 | |
On this episode we are joined by Dr. Warren Whyte. Dr. Whyte heads up ConcertAI’s health equity and trial diversity initiatives through the ERACE (Engaging Research to Achieve Cancer Care Equity) program . As a leader in this field, his work and the work of his team has influenced all of what ConcertAI brings to clients, customers, and biopharma partners. This includes the integration of SDOH with all of our datasets - a first-in-class for anybody in the RWD Industry. His work also influenced integrating health equity and trial diversity considerations into all of our technology solutions. There couldn't be a more important topic with a more influential individual in the field!
| |||
| 03 Apr 2023 | Exploring Globalization and the Power of Biopharma Innovation feat. Jitendra Gupta | 00:23:55 | |
ConcertAI is grateful to have a presence in a geography with such a fast pace of technical innovation, and is excited for the future. Tune in to the latest episode of The ConcertAI Podcast, hosted by CEO Jeff Elton! This week's episode explores the topic of globalizing healthcare and biopharma technical innovation. Jeff and Jitendra Gupta talks about what it really means to be a global company, and the amazing progress that India has made in advancing the healthcare and biopharma technology industry. Don't miss out on this insightful episode!
| |||
| 28 Apr 2023 | The Future of Digital Pathology with PathAI feat. Dr. Andy Beck | 00:36:13 | |
In this episode, we're thrilled to have Dr. Andy Beck, the Co-founder and CEO of PathAI, one of the leading digital pathology companies, as our guest. Digital pathology is transforming the accessibility of decision rules and decision augmentation, creating translational assets and changing how clinical development occurs. Dr. Beck shares insights on the progress and life of digital pathology, and how it's transforming healthcare.
| |||
| 18 Apr 2023 | Exploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter | 00:33:53 | |
A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model. Join us as we explore these exciting developments and learn how they are changing the biopharma landscape.
| |||
| 18 Apr 2023 | Exploring the Future of Clinical Trials pt. 2 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter | 00:25:40 | |
In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game. Bristol Myers Squibb's Marisa and Gaelan share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community settings. The platform not only meets FDA imperatives but also makes much-needed medicines available to a wider array of patients. Join us as we dive deep into the exciting developments in clinical research and discover how technology is improving patient outcomes.
| |||
| 25 Jan 2024 | Season 2 Introduction | 00:02:09 | |
We're back with The ConcertAI Podcast for Season Two!
| |||
| 12 Mar 2024 | CancerLinQ's Transformational Role in Oncology with Dr. Robert Miller | 00:34:17 | |
Jeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from community practice to shaping CancerLinQ, revealing insights into the network's growth and its pivotal role in improving patient care. The episode delves into the transformation of quality measures, the burgeoning role of electronic health records, and the automation of data to enhance the quality and reach of oncological care. As CancerLinQ evolves, discover its expanding capabilities, the drive towards patient-centric care, and the influence on CancerLinQ's partnerships, particularly with ASCO. This is a must-listen for professionals seeking to understand the landscape of data-driven healthcare improvements. Tune in to explore the trajectory of oncology practice transformation with two industry leaders at the helm.
| |||
| 30 Jan 2024 | Real-World Data in Oncology: Navigating the New Frontiers feat. Jennifer Rider | 00:33:26 | |
In this captivating episode of The ConcertAI Podcast, we dive deep with Jennifer Rider, a renowned cancer epidemiologist. Jennifer shares her journey from academia to the dynamic world of real-world data (RWD) and its vital role in oncology research. We explore how RWD is transforming the landscape of prostate cancer studies and its increasing importance in regulatory decision-making.
| |||
| 08 Feb 2024 | Empowering Community Oncology: Challenges & Innovations | 00:36:10 | |
The second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to improve clinical research in community oncology, making trials more accessible and reflective of standard care populations. Dr. Blau, motivated by a dream to cure cancer, emphasized the importance of maintaining the independence of oncology practices for superior patient care. Merillat, with extensive experience in research, is dedicated to expanding trial access, especially for underserved populations. Exigent, by leveraging real-world data and collaborative efforts, seeks to enhance trial quality and speed, emphasizing a patient-centric approach that prioritizes the right trials for patients. This innovative model showcases the potential of community oncology to lead in research and patient care, underscoring the significance of independent practices in the healthcare ecosystem.
| |||
| 21 Feb 2024 | Evolution in Oncology Care feat. Dr. George W. Sledge, Jr. | 00:30:44 | |
Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular diagnostic testing and how comprehensive data sets are revolutionizing personalized medicine. Delving into topics like the rise of liquid biopsies, which enable non-invasive, next-gen sequencing, they highlight the potential for easier and safer tumor monitoring. Challenges like the limitations of analyzing small populations are addressed, emphasizing the value of large-scale, actionable databases in understanding diseases like breast cancer. They also discuss the future of molecular diagnostics in streamlining cancer prevention trials and the need to look beyond "gateway mutations" for a deeper understanding of dynamic cancer evolution. A key theme is the collaborative synergy between ConcertAI and Caris Life Sciences, emphasizing the goal of producing high-quality, meaningful data that can shape the future of oncological research and care.
| |||
| 15 Feb 2024 | Next-Gen Oncology: Caris Life Sciences & ConcertAI's Vision feat. Dr. David Spetzler | 00:25:30 | |
In this engaging episode, David Spetzler, President of Caris Life Sciences, and Jeff Elton, CEO of ConcertAI, discuss the transformative power of combining clinical insights and advanced AI technologies to revolutionize patient care in oncology. Highlighting their collaborative efforts, they emphasize the critical role of comprehensive data analysis, from leveraging longitudinal clinical records to employing next-generation sequencing for personalized treatment strategies. The conversation underscores a shared commitment to advancing medical science by accelerating the development and validation of new therapies, ultimately aiming to enhance patient outcomes through precision medicine. Through this partnership, they envision a future where diagnostics and targeted treatment strategies significantly extend human life years, demonstrating the profound impact of integrating cutting-edge technology and collaborative innovation in healthcare. Watch the live video interview here:
| |||
| 17 Sep 2024 | Prostate Cancer Awareness with Steve Osunsami: Screening, Survival, and Breaking Stigmas | 00:40:40 | |
In this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screening and awareness. Steve shares his personal journey with prostate cancer, from initial diagnosis at age 41 to treatment and recovery. He highlights the significance of early detection, particularly for high-risk groups such as African American men, and the life-saving potential of regular PSA testing. Through his candid storytelling, Steve addresses the the challenges men face regarding prostate cancer, including the stigma around sexual function, and advocates for increased awareness and proactive health measures. This episode is a powerful reminder of the importance of self-advocacy and the need for tailored healthcare guidelines to better serve diverse populations.
| |||
| 05 Sep 2024 | Breaking New Ground in Prostate Cancer Research feat. Jennifer Rider and Kathryn Penney | 00:24:43 | |
September marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welcomes Jennifer Rider and Kathryn Penney to our studio in Harvard Square, Cambridge, MA. Both guests are distinguished cancer epidemiologists who bring a wealth of knowledge and experience in prostate cancer research. In this episode, you will hear about the personal journeys of our guests into the field of cancer research, the significant advancements they have contributed to, and the vital role of genetic studies in improving patient care. The discussion delves into the importance of the Gleason scoring system for determining patient prognosis and explores the integration of AI and digital pathology to enhance diagnosis and treatment strategies. This conversation is essential for anyone interested in the latest in prostate cancer research and the evolving treatment strategies that could redefine patient outcomes.
| |||
| 31 Mar 2025 | The Future of Drug Development: AI, RWD, and Regulatory Insights feat. Evidera's Ariel Berger | 00:42:15 | |
In this episode of The ConcertAI Podcast, Jeff Elton, CEO of ConcertAI, engages with Ariel Berger, Executive Director of Integrated Solutions of Evidera, part of the PPD™ clinical research business of Thermo Fisher Scientific, to explore the innovative uses of real-world data (RWD) in regulatory settings, particularly in oncology. They discuss the critical role of RWD in shaping clinical trials and supporting regulatory decisions, emphasizing its growing importance in the regulatory approval process. The conversation also delves into the complexities of integrating AI and advanced data technologies to enhance trial designs and outcomes, highlighting how these tools are revolutionizing drug development efficiency and precision in patient care. Through insightful dialogue, the episode illuminates the transformative impact of these technologies on the future of healthcare and precision medicine.
| |||
| 18 Mar 2025 | Accelerating Healthcare Innovation with NVIDIA feat. Rory Kelleher | 00:44:00 | |
In the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of AI in healthcare and life sciences. With a rich background at NVIDIA, Rory shares insights into NVIDIA’s journey from a GPU manufacturer to a leader in AI computation. This episode explores NVIDIA’s initiatives like the Clara platform, which seamlessly integrates AI into medical imaging and genomics, significantly accelerating drug discovery and patient care processes. Rory and host, Jeff Elton, discuss the collaborative dynamics between ConcertAI and NVIDIA, focusing on innovative AI-driven models designed to revolutionize clinical trial design and execution. The future looks promising with the potential development of reasoning models and multimodal patient foundation models, poised to deliver personalized healthcare solutions more effectively. Tune in to discover how NVIDIA's technology is paving the way for advancements in life sciences.
| |||
| 16 Apr 2025 | From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials | 00:21:46 | |
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and the strategic shift toward real-time decision-making, this conversation is essential listening for anyone in translational medicine or clinical development.
| |||